title: Challenging problems in advanced malignancy: Case 3. Imatinib mesylate-induced interstitial pneumonitis.
authors.affiliation: Sylvester Cancer Center, Miami, FL, USA.
authors.forename: Manuel F
authors.initials: MF
authors.lastname: Rosado
authors.forename: Elio
authors.initials: E
authors.lastname: Donna
authors.forename: Yeon S
authors.initials: YS
authors.lastname: Ahn
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000188:drug therapy*; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate